Registered entities
Syros Pharmaceuticals, Inc.
Reg. No. 45-3772460United States
Innovation
34 patent families (19 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,898 times.
| Year | Filings |
|---|---|
| 2015 | 4 |
| 2016 | 10 |
| 2017 | 6 |
| 2018 | 12 |
| 2019 | 15 |
| 2020 | 13 |
| 2021 | 22 |
| 2022 | 16 |
| 2023 | 14 |
| 2024 | 10 |
| 2025 | 4 |
| 2026 | 2 |
Investor mix
23 investors on record; lead investors include Polaris Partners, Redmile Group, Aisling Capital; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 13 | 57% |
| Private equity | 4 | 17% |
| Bank & private debt | 2 | 9% |
| Other / undisclosed | 4 | 17% |